Retornaz Frédérique, Duque Gustavo
Division de gériatrie, Université McGill, Hôpital Général Juif, Montréal, Québec, Canada.
Presse Med. 2006 Oct;35(10 Pt 2):1547-56. doi: 10.1016/s0755-4982(06)74850-3.
Osteoporosis is a frequent disease among the elderly and has major consequences in terms of mortality, morbidity and cost. Guidelines for diagnostic procedures are often difficult to apply in frail, elderly patients with multiple comorbidities. Bisphosphonates are the reference treatment for the elderly, combined with vitamin D and calcium supplementation. Vitamin D deficiency must also be treated to prevent falls and fractures. Strontium ranelate is a promising treatment in this population. Fall prevention is a major part of osteoporosis management. The potential benefit of hip protectors is questionable, even in institutionalized patients.
骨质疏松症在老年人中是一种常见疾病，在死亡率、发病率和成本方面具有重大影响。诊断程序指南在体弱多病且患有多种合并症的老年患者中往往难以应用。双膦酸盐是老年人的参考治疗药物，同时补充维生素D和钙。维生素D缺乏也必须得到治疗以预防跌倒和骨折。雷奈酸锶在这一人群中是一种有前景的治疗方法。预防跌倒是骨质疏松症管理的重要组成部分。即使在机构养老的患者中，髋部保护器的潜在益处也存在疑问。
